Alecta Tjanstepension Omsesidigt Buys 43,100 Shares of Intuitive Surgical, Inc. $ISRG

Alecta Tjanstepension Omsesidigt boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 212,800 shares of the medical equipment provider’s stock after purchasing an additional 43,100 shares during the period. Alecta Tjanstepension Omsesidigt owned about 0.06% of Intuitive Surgical worth $95,160,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ISRG. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the last quarter. Sivia Capital Partners LLC grew its stake in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after acquiring an additional 34 shares during the period. Schnieders Capital Management LLC. increased its holdings in Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the last quarter. Westover Capital Advisors LLC bought a new stake in Intuitive Surgical in the 2nd quarter valued at about $206,000. Finally, Empowered Funds LLC raised its stake in Intuitive Surgical by 26.4% in the 2nd quarter. Empowered Funds LLC now owns 11,793 shares of the medical equipment provider’s stock valued at $6,408,000 after acquiring an additional 2,465 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,362 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the sale, the senior vice president directly owned 3,554 shares of the company’s stock, valued at $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president owned 409 shares of the company’s stock, valued at approximately $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 32,943 shares of company stock valued at $17,279,568 in the last 90 days. 0.70% of the stock is owned by company insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Company fundamentals and market positioning — Intuitive reported a strong January quarter (beats on revenue and EPS, ~19% revenue growth year‑over‑year) and is pursuing lower‑cost da Vinci systems to target fast‑growing ambulatory surgery centers, which could expand procedure volume outside hospitals over time. No external link
• Neutral Sentiment: Sector and competitive news with limited direct impact — other medtech product launches and approvals in the broader ecosystem (e.g., Merit Medical’s new esophageal stent) are being reported but do not directly displace Intuitive’s robotic surgery franchise. MMSI Launches Resilience TTS Stent for Esophageal Fistulas, Strictures
• Negative Sentiment: FDA regulatory flag — Intuitive was flagged by the FDA over a medical device issue, which raises near‑term regulatory and operational risk concerns; such notices can prompt customer caution, warranty/repair costs, or increased oversight that pressure sentiment. Intuitive Surgical flagged by FDA over medical device issue
• Negative Sentiment: Analyst outlook softened — UBS cut its price target from $570 to $550 and set a “neutral” rating, reducing near‑term upside expectations and likely contributing to selling pressure; the new target still implies some upside versus current levels but reflects more cautious sentiment. Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $550.00 at UBS Group

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on ISRG shares. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Royal Bank Of Canada raised their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $614.95.

Intuitive Surgical Stock Down 1.0%

Intuitive Surgical stock opened at $477.73 on Thursday. The stock has a market cap of $169.66 billion, a price-to-earnings ratio of 60.55, a PEG ratio of 3.72 and a beta of 1.66. The business has a 50-day simple moving average of $507.10 and a 200 day simple moving average of $512.85. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.